Corrs Chambers Westgarth

Kicking off its appeal of a finding that it couldn't walk away from a $672 million merger agreement with Mayne Pharma, US drug company Cosette has told a court that Mayne was not upfront about its financial position prior to the deal.

Venture capital firm EVP has sought the court’s leave to proceed with claims against Strongroom AI founder and former director Christopher Durre, despite his financial state. 

Dexus has lost its case over the validity of a default notice issued by Melbourne Aiport's operator, with a judge saying the real estate asset manager breached the company's confidentiality and "irrevocably undermined" its relationship with fellow shareholders.

Heads may roll after a court on Friday rejected the evidence of key Dexus employees at trial over a breach of APAC's shareholder deed, in a ruling that revealed some insiders suspected the "embarassing blunder" would come back to bite.

Popular Swiss sneaker company On Clouds has prevailed in its challenge to a trade mark by sustainable footwear brand Cyclonic.

AstraZeneca has slammed Pharmacor's defence to claims it infringed a patent for blockbuster diabetes drug Forxiga as a "complete shot in the dark", as the drug maker unsuccessfully fought orders to produce documents from a UK case.

An employee of e-commerce merchandise importer New Aim wants the High Court to overturn a ruling that found he breached his duty of confidence by providing competitors with contact details of the company's suppliers, stored on WeChat on his personal phone.

Apple will bring a “full-bodied” opposition to a bid to expand a class action over the running of its App Store, after a judge found the tech company engaged in anti-competitive conduct in the app marketplace last year. 

A developer linked to Keystone Asset Management has failed to persuade the Full Federal Court to exempt three family trusts from a $158 million freezing order.

Mayne Pharma cannot access invoices from Cosette’s solicitors at Corrs Chambers Westgarth, with a judge saying he was not hopeful that they would help to resolve a costs fight related to litigation over their collapsed $672 million merger.